Effects of weight cycling on urinary catecholamines: Sympathoadrenal role in refeeding hypertension

Journal of Hypertension

Volumn 16, Issue 12 SUPPL., 1998, Pages 2001-2005

  Ernsberger, Paul ^a,b   Koletsky, Richard J ^a   Kilani, Ahmad ^a   Viswan, Gita ^a   Bedol, David ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cardiovascular regulation; Hypertension in obesity; Metabolic efficiency; Refeeding; Sympathetic nervous system; Weight cycling

Indexed keywords

ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; DOPAMINE; NORADRENALIN;

ADRENALIN URINE LEVEL; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE; BODY WEIGHT; CALORIC RESTRICTION; CATECHOLAMINE URINE LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE URINE LEVEL; FEMALE; HYPERTENSION; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; NORADRENALIN URINE LEVEL; OBESITY; PRIORITY JOURNAL; RADIOENZYMATIC ASSAY; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; REFEEDING; SPONTANEOUSLY HYPERTENSIVE RAT; WEIGHT REDUCTION;

EID: 0032438404     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816121-00022     Document Type: Conference Paper

References (24)

1. Blackburn GL, Wilson GT, Kanders BS, Stein LJ, Lavin PT, Adler J, Brownell KD. Weight cycling: the experience of human dieters. Am J Clin Nutr 1989; 49(suppl):1105-1109.
2. Rodin J, Radke-Sharpe N, Rebuffë-Scrive M, Greenwood MR. Weight cycling and fat distribution, Int J Obes 1990; 14:303-310.
3. Brownell KD, Rodin J. Medical, metabolic, and psychological effects of weight cycling. Arch Intern Med 1994; 154:1325-1330.
4. Hamm P, Shekelle RB, Stamler J. Large flucuations in body weight during young adulthood and twenty-five-year risk of coronary death in men. Am J Epidemiol 1989; 129:312-318.
5. Lissner L, Odell PM, D'Agostino RB, Stokes J, III, Kreger BE, Belanger AJ, et al, Variability of body weight and hearth outcomes in the Framingham population. N Engl J Med 1991; 324:1839-1844.
6. Ernsberger P, Koletsky RJ. Weight cycling and mortality: support from animal studies. J Am Med Assoc 1993; 269:1116-1116.
7. Ernsberger P, Nelson DO. Refeeding hypertension in dietary obesity. Am J Physiol 1988; 254:R47-R55.
8. Ernsberger P, Nelson DO. Effects of fasting and refeeding on blood pressure are determined by nutritional state, not by body weight change. Am J Hypertens 1988; 1:153S-157S.
9. Ernsberger P, Koletsky RJ, Baskin JZ, Foley M. Refeeding hypertension in obese SHR. Hypertension 1994; 24:699-705.
10. Koletsky RJ, Ernsberger P. Obese SHR (Koletsky rat). A model for the interactions between obesity and hypertension. In Sassard J. (ed) Genetic hypertension. John Libbey Eurotext Ltd. 1992: 373-375.
11. Koletsky S. Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 1975; 80:129-142.
12. Koletsky RJ, Boccia J, Ernsberger P. Acceleration of renal disease in obese SHR by exacerbation of hypertension. Clin Exp Pharmacol Physiol 1995; 22:S254-S256.
13. Ernsberger P, Koletsky RJ, Baskin JZ, Collins LA. Consequences of weight cycling in obese spontaneously hypertensive rats. Am J Physiol Regul Integr Camp Physiol 1996; 270:R864-R872.
14. Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med 1978; 298:1295-1301.
15. Ernsberger P, Feinland G, Meeley MP, Reis DJ. Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance. Am J Hypertens 1990; 30:90-97.
16. Ernsberger P, Shen I-H. Membrane localization and guanine nucleotide sensitivity of medullary I,-imidazoline binding sites. Neurochem Int 1997; 30:17-23.
17. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal Biochem 1980; 107:220-239.
18. Sowers JR, Whitfield LA, Catania RA, Stern N, Tuck ML, Dornfeld L, et al. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 1982; 54:1181-1186.
19. Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K, et al. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 1996; 14:130-131.
20. Friedman JE, Ishizuka T, Liu S, Bedol D, Koletsky RJ, Ernsberger P. Metabolic consequences of a nonsense mutation in the leptin receptor gene (fak) in the obese spontaneously hypertensive Koletsky rat (SHROB). Exp Clin Endocrinol Diabetes 1997; 105(suppl 3):82-84.
21. Hiraoka J, Hosoda K, Ogawa Y, lkeda K, Nara Y, Masuzaki H, et al. Augmentation of obese (ob) gene expression and leptin secretion in obese spontaneously hypertensive rats (obese SHR or Koletsky rats). Biochem Biophys Res Commun 1997; 231:582-585.
22. Goldstein DS, Kopin IJ. The autonomic nervous system and catecholamines in normal blood pressure control and in hypertension. In Laragh JH and Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management. New York: Raven Press, 1990: 711-747.
23. Pfohl M, Luft D, Blomberg I, Schmulling R-M. Long-term changes of body weight and cardiovascular risk factors after weight reduction with group therapy and dexfenfluramine. Int J Obes 1994; 18:391-395.
24. Wing RR, Jeffery RW, Hellerstedt WL. A prospective study of effects of weight cycling on cardiovascular risk factors. Arch Intern Med 1995; 155:1416-1422.